Home » Keryx Cancer Drug Improves Survival in Phase II Trial
Keryx Cancer Drug Improves Survival in Phase II Trial
February 3, 2010
Keryx’s potential first-in-class treatment for advanced metastatic colon cancer improved overall survival in one of many Phase II trials for several
types of tumors, and the company hopes to finalize a Phase III trial design in the next three months.